[Federal Register Volume 63, Number 31 (Tuesday, February 17, 1998)]
[Notices]
[Page 7813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3875]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice if hereby given of the following 
National Institute on Drug Abuse (NIDA) Special Emphasis Panel 
meetings.

    Purpose/Agenda: To review and evaluate grant applications and 
contract proposals.
    Name of Committee: NIDA Special Emphasis Panel (SBIR Contract 
Review, ``A New Experimental Chamber for the Long-term Study of 
Complex Behavior and Neurol Function in Rodents'').
    Date: February 25, 1998.
    Time: 10 a.m.
    Place: National Institute on Drug Abuse, NIH, 5600 Fishers Lane, 
Room 10-49, Rockville, MD 20857.
    Contact Person: Mr. Eric Zatman, Contract Review Specialist, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, Telephone 
(301) 443-1644.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

    Name of Committee: NIDA Special Emphasis Panel (Clinical 
Neuroscience and Imaging).
    Date: March 12, 1998.
    Time: 9:00 a.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Mark Swieter, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-42, Telephone 
(301) 443-2620.

    The meetings will be closed in accordance with provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The 
applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Scientist Development, Research Scientist Development, 
and Research Scientist Awards; 93.278, Drug Abuse National Research 
Service Awards for Research Training; 93.279, Drug Abuse Research 
Programs, National Institutes of Health)

    Dated: February 9, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-3875 Filed 2-13-98; 8:45 am]
BILLING CODE 4140-01-M